Jack Schalken

18PUBLICATIONS
62CO-AUTHORS
Molecular targetsInnate immunityMedical biotechnology diagnostics (incl. biosensors)Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (18)

|Nov 01, 2025
Molecular reflex testing in patients with early metastatic castration-resistant prostate cancer within the PROMPT-study.

Iris S H Kloots, Peter H J Slootbeek, Sofie H Tolmeijer

|Feb 26, 2025
Hyaluronic acid: Function and location in the urothelial barrier for bladder pain syndrome/interstitial cystitis, an in vitro study.

Charlotte J van Ginkel, Cléo D M Baars, Dorien M Tiemessen

|Oct 26, 2023
Therapeutic biomarkers in metastatic castration-resistant prostate cancer: does the state matter?

Peter H J Slootbeek, Sofie H Tolmeijer, Niven Mehra

|Mar 30, 2023
Early On-treatment Changes in Circulating Tumor DNA Fraction and Response to Enzalutamide or Abiraterone in Metastatic Castration-Resistant Prostate Cancer.

Sofie H Tolmeijer, Emmy Boerrigter, Takayuki Sumiyoshi

|Jan 17, 2023
The future of patient-derived xenografts in prostate cancer research.

Mitchell G Lawrence, Renea A Taylor, Georgia B Cuffe

|Jul 09, 2022
Clinical use of the mRNA urinary biomarker SelectMDx test for prostate cancer.

Wieke C H Visser, Hans de Jong, Sandra Steyaert

Pageof 3

Frequent Collaborators

7 joint publications

Niven Mehra

5 joint publications

Peter H J Slootbeek

3 joint publications

Gerald W Verhaegh

3 joint publications

Inge M van Oort